Dividend Daily RSS Feed RSS
Dividend Stocks

The Dividend Daily

Dividend stocks - News, notes, updates, and analysis, delivered fresh daily

Pfizer Suffers Drug Setback, But a Deal May be in the Works (PFE)

By Dividend.com Staff
September 9th, 2008

pfizer-suffers-drug-setback-but-a-deal-may-be-in-the-works-pfe

Pfizer (PFE) announced today that it will globally withdraw all Dalbavancin marketing applications for the treatment of complicated skin and skin structure infections in adults, including the U.S. new drug application and the European marketing authorization application.

Dividend.com archives (articles more than 30 days old) are only available to Dividend.com Premium subscribers.

Sign up for a Dividend.com Premium account for instant access to article archives, stock ratings on over 2,000 dividend-paying stocks, and much more! FREE TRIAL available!

Comments on this Article COMMENTS ON THIS ARTICLE

Leave a Reply

Your Comments:

Please type the Security Words below:

About This Article ABOUT THIS ARTICLE

You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Disclaimer: Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. The author is not registered as an investment adviser. The author may or may not hold positions in the securities mentioned in this article or video. The author relies upon the "publisher's exclusion" from the definition of "investment adviser" as provided under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws.